GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » Cyclically Adjusted PB Ratio

Laboratorio Reig Jofre (XMAD:RJF) Cyclically Adjusted PB Ratio : 0.94 (As of May. 15, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre Cyclically Adjusted PB Ratio?

As of today (2024-05-15), Laboratorio Reig Jofre's current share price is €2.82. Laboratorio Reig Jofre's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €3.00. Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio for today is 0.94.

The historical rank and industry rank for Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio or its related term are showing as below:

XMAD:RJF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.53   Med: 0.82   Max: 1.87
Current: 0.96

During the past years, Laboratorio Reig Jofre's highest Cyclically Adjusted PB Ratio was 1.87. The lowest was 0.53. And the median was 0.82.

XMAD:RJF's Cyclically Adjusted PB Ratio is ranked better than
72.11% of 667 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs XMAD:RJF: 0.96

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Laboratorio Reig Jofre's adjusted book value per share data for the three months ended in Dec. 2023 was €2.593. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €3.00 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Chart

Laboratorio Reig Jofre Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 1.33 1.00 0.69 0.75

Laboratorio Reig Jofre Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.69 0.82 0.80 0.75

Competitive Comparison of Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio falls into.



Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.82/3
=0.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorio Reig Jofre's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Laboratorio Reig Jofre's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.593/121.2698*121.2698
=2.593

Current CPI (Dec. 2023) = 121.2698.

Laboratorio Reig Jofre Quarterly Data

Book Value per Share CPI Adj_Book
201309 4.667 100.597 5.626
201312 4.601 101.306 5.508
201403 4.754 100.139 5.757
201406 4.675 101.081 5.609
201409 4.752 100.441 5.737
201412 1.875 100.251 2.268
201503 1.964 99.474 2.394
201506 1.986 101.138 2.381
201509 2.147 99.559 2.615
201512 1.995 100.268 2.413
201603 2.041 98.638 2.509
201606 2.046 100.333 2.473
201609 2.065 99.737 2.511
201612 2.120 101.842 2.524
201703 2.156 100.896 2.591
201706 2.163 101.848 2.575
201709 2.118 101.524 2.530
201712 2.218 102.975 2.612
201803 2.249 102.122 2.671
201806 2.254 104.165 2.624
201809 2.249 103.818 2.627
201812 2.313 104.193 2.692
201903 2.351 103.488 2.755
201906 2.330 104.612 2.701
201909 2.318 103.905 2.705
201912 2.355 105.015 2.720
202003 2.387 103.469 2.798
202006 2.401 104.254 2.793
202009 2.420 103.521 2.835
202012 2.420 104.456 2.810
202103 2.470 104.857 2.857
202106 2.468 107.102 2.794
202109 2.463 107.669 2.774
202112 2.458 111.298 2.678
202206 2.492 118.044 2.560
202209 2.463 117.221 2.548
202212 2.508 117.650 2.585
202306 2.574 120.278 2.595
202309 2.608 121.343 2.606
202312 2.593 121.270 2.593

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Laboratorio Reig Jofre  (XMAD:RJF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Reig Jofre (XMAD:RJF) Business Description

Traded in Other Exchanges
Address
Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.